欧特普奥莱拉西亚马尔蒂乌斯 (Açaí) 提取物和抵抗运动调节高血压大鼠的心脏参数
Pilar Barbosa de Meireles1, Denise Coutinho de Miranda1, Anselmo Gomes de Moura1
1Department of Physical Education and Nutrition, Governador Ozanam Coelho University Center, Ubá 36506-022, MG, Brazil.
Life (Basel, Switzerland)
|September 28, 2024
概括
抵抗运动和阿补充剂通过降低血压和增强心脏功能来改善高血压大鼠的心血管健康. 结合这两种治疗方法,为这些心脏参数提供了最好的结果.
科学领域:
- 心血管生理学心血管生理学
- 运动科学 运动科学
- 营养生物化学 营养生物化学
背景情况:
- 高血压与有害的心脏改造和氧化压力有关.
- 抵抗运动训练和açaí补充剂是管理高血压相关心血管问题的潜在干预措施.
研究的目的:
- 评估抵抗运动训练和açaí补充剂对自发高血压大鼠心脏参数的综合和单独影响.
- 研究这些干预措施对缩血压,心脏结构,功能和氧化应激标志物的影响.
主要方法:
- 维斯特和自发高血压大鼠 (SHR) 被分为五组:控制,高血压,训练高血压,Açaí的高血压和Açaí训练高血压.
- 干预措施包括抵抗运动 (登) 和açaí补充剂 (3g/kg).
- 测量包括静脉压,体检,心声学,组织学和左心室 (LV) 的氧化应激分析.
主要成果:
- 抵抗运动和阿补充剂在高血压大鼠中降低了缩血压.
- 受过训练的小组表现出更好的射出和缩短分数,表明心脏功能更好.
- 治疗缓解了高血压引起的LV细胞外基质,细胞直径,马隆迪化度的增加,并恢复了催化酶活性.
结论:
- 抵抗运动训练和阿补充剂在高血压大鼠中诱导了积极的心血管适应.
- 抵抗运动和açaí补充剂的组合提供了协同效益,增强了这些心血管保护作用.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Exercise and Cardiac Output
938
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
938
Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320


